Safety and Efficacy of Non‐Steroidal Topical Aryl Hydrocarbon Receptor Agonists for the Treatment of Atopic Dermatitis: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

Documenti analoghi

• Atopic Dermatitis
  Pubblicazione: (2026)
• Topical Steroid Withdrawal: A Perspective of Australian Dermatologists
  di: Andrew Awad, et al.
  Pubblicazione: (2025)
• Ruxolitinib cream improves outcomes in atopic dermatitis: An updated systematic review and meta‐analysis
  di: Laura Ghanem, et al.
  Pubblicazione: (2026)
• The Use of Dupilumab for Severe Atopic Dermatitis in Patients Aged Under 12‐Years
  di: Laura Wheller, et al.
  Pubblicazione: (2026)
• Costs Associated With Inpatient Management of Atopic Dermatitis in Paediatric Patients: An Australian Perspective
  di: Zoe Lee, et al.
  Pubblicazione: (2026)